Release Notes:  Version 20230814

About this release 

This release (version 20230814) provides the latest updates to the Canadian Clinical Drug Data Set in English and French.  A separate InfoScribe location for the French supporting documents, including the French Release Notes, can be found here

There is no change to the Technical Specification or the Editorial Guidelines.

The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.  

Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page

General Notes

The following files are available as full release files within this version:

  • Manufactured Product,
  • Non-proprietary Therapeutic Product,
  • Therapeutic Moiety,
  • Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in English (MP-NTP-TM Relationship),
  • Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in French (Relation PM-PTC-FT), 
  • Special Groupings, 
  • Coded Attribute, and
  • Device Non-proprietary Therapeutic Product.

The "Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.

NOTE:  The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.  

This release reflects additions and changes that have occurred in DPD since the last CCDD release. 

Non-proprietary Therapeutic Product (NTP)

There is 1 new deprecated concept in this version resulting from an update to the basis of strength substance in DPD.

ntp_code

ntp_formal_name

ntp_fr_description

Change

New ntp_code

New ntp_formal_name

New ntp_fr_description

9013200

lidocaine hydrochloride 0.8 % cutaneous gel

chlorhydrate de lidocaïne 0,8 % gel cutané

Deprecated

9014894

lidocaine (lidocaine hydrochloride) 0.8 % cutaneous gel

lidocaïne (chlorhydrate de lidocaïne) 0,8 % gel cutané


Manufactured Product (MP)

The following MP formal name change has occurred resulting in the newly deprecated NTP shown above.  

mp_code

mp_formal_name

July Release

mp_fr_description

July Release

mp_formal_name (new)

August Release

mp_fr_description (new)

August Release

02471833

EQUATE AFTER SUN GEL WITH LIDOCAINE (lidocaine hydrochloride 0.8 % cutaneous gel) FRUIT OF THE EARTH, INC

EQUATE AFTER SUN GEL WITH LIDOCAINE (chlorhydrate de lidocaïne 0,8 % gel cutané) FRUIT OF THE EARTH, INC

EQUATE AFTER SUN GEL WITH LIDOCAINE (lidocaine (lidocaine hydrochloride) 0.8 % cutaneous gel) FRUIT OF THE EARTH, INC

EQUATE AFTER SUN GEL WITH LIDOCAINE (lidocaïne (chlorhydrate de lidocaïne) 0,8 % gel cutané) FRUIT OF THE EARTH, INC

Questions, Concerns, Changes

Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]

  • No labels